Skip to main content

and
  1. Article

    Open Access

    The ocrelizumab wearing-off phenomenon is associated with reduced immunomodulatory response and increased neuroaxonal damage in multiple sclerosis

    The wearing-off phenomenon is common in people with multiple sclerosis (MS) treated with ocrelizumab. We aim to evaluate the presence and severity of wearing-off to ocrelizumab in relation to demographic and M...

    Isabel Monteiro, Valerio Nicolella, Mariano Fiorenza in Journal of Neurology (2024)